Medicine and Dentistry
Asthma
100%
Chronic Obstructive Pulmonary Disease
63%
Lung
48%
Severe Asthma
41%
middle age
31%
Spirometry
28%
Forced Expiratory Volume
26%
Forced Vital Capacity
23%
Diseases
20%
Clinical Trial
18%
Cohort Analysis
17%
Biological Therapy
17%
Sarcopenia
15%
Chronic Cough
15%
Lifespan
15%
Eosinophilic
15%
Pediatrics
15%
Biological Product
14%
Prevalence
14%
Hazard Ratio
14%
Cross Sectional Study
12%
Chronic Airway Disease
10%
Clinical Research
10%
Pulmonary Hypertension
10%
Interstitial Lung Disease
10%
Odds Ratio
10%
Comorbidity
9%
Monoclonal Antibody
9%
Magnetic Resonance Imaging of Brain
9%
Genome Wide Association Study
9%
Primary Health Care
8%
Nasal Polyp
8%
Silo-Filler's Disease
8%
Cohort Effect
8%
Quality of Life
7%
Lung Function
7%
Systemic Scleroderma
7%
Hand Grip
7%
Prospective Cohort Study
7%
Personalized Medicine
7%
Chronic Depression
7%
Immunoglobulin A
7%
Connective Tissue Disease
7%
Airway Obstruction
7%
All Cause Mortality
7%
Brain Blood Flow
7%
Health Care Provider
7%
Multifactorial Disease
7%
Monoclonal Antibody Therapy
7%
Adverse Event
7%
Biochemistry, Genetics and Molecular Biology
Forced Expiratory Volume
36%
Genome-Wide Association Study
32%
Airflow
26%
Single-Nucleotide Polymorphism
24%
Forced Vital Capacity
23%
Allele
21%
Genetic Divergence
21%
Genetics
20%
Prevalence
17%
Lifespan
16%
Comorbidity
16%
Clinical Trial
15%
Epigenome
15%
Lung Function
15%
DNA Methylation
14%
Gene Expression
13%
Exome
12%
Genetic Risk
10%
Clinical Research
10%
Body Mass
9%
Cross Sectional Study
9%
Gene Locus
9%
Genotyping
9%
Genetic Association
9%
Randomized Controlled Trial
9%
Pharmacogenetics
8%
Genome Wide Association Study
8%
Polygenic Score
8%
All Cause Mortality
8%
Single Nucleotide Polymorphism
7%
Genetic Architecture
7%
Prospective Cohort Study
7%
Agonist
7%
Autofluorescence
7%
Grip Strength
7%
Effectiveness Study
7%
Systolic Blood Pressure
7%
Exocyst
7%
Advanced Glycation End-Product
7%
Clinical Study
7%
Drug Megadose
7%
Triglyceride
7%
Apolipoprotein E
7%
Mental Capacity
7%
Protein Characterization
7%
Cytosine
7%
Guanine
7%
Xanthophyll
7%
Lutein
7%
Genetic Correlation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
94%
Chronic Obstructive Lung Disease
37%
Diseases
18%
Chronic Cough
16%
Biological Product
13%
Muscarinic Receptor Blocking Agent
13%
Prevalence
12%
Cohort Study
10%
Infection
10%
Monoclonal Antibody
8%
Lung Disease
8%
Clinical Trial
8%
Immunoglobulin
7%
Cardiovascular Agent
7%
Disproportionality Analysis
7%
Adverse Event
7%
Pulmonary Hypertension
7%
Chronic Depression
7%
Cross Sectional Study
7%
Immunoglobulin A
7%
Interstitial Lung Disease
7%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
7%
Chronic Pain
7%
Benralizumab
5%
Reslizumab
5%